Nigel McCracken
Chief Tech/Sci/R&D Officer at BERGENBIO ASA
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| James Foster | M | 37 | 11 years | |
| Sally Bennett | M | 52 | 4 years | |
| Sveinung Hole | M | 57 | 14 years | |
| Pierre Jullian | M | - |
Debiopharm International SA
 Debiopharm International SA Pharmaceuticals: MajorHealth Technology Debiopharm International SA operates as a biopharmaceutical development company with focus on biologics and drug evaluation, licensing and development. It formulates and develops products for the treatment of cancer, endometriosis, uterine fibroids and hepatitis. The company was founded in 1979 and is headquartered in Lausanne, Switzerland. | 6 years |
| Evan Norton | M | 49 | - | |
| Martin Olin | M | 55 | 3 years | |
| Yair Erez | M | 50 | - | |
| Rune Skeie | M | 51 | 6 years | |
| Nelson Haight | M | 58 | - | |
| Mark Ternouth | M | 56 | - | |
| James Barnes | M | - | 5 years | |
| Gayle Mills | F | 69 | 3 years | |
| Tomasz George | M | 40 | 3 years | |
| Anders Lennart Tullgren | M | 63 | 2 years | |
| Debbie Molyneux | F | - | 5 years | |
| Debra Stephanie Barker | M | 61 | 5 years | |
| Cristina Oliva | M | - | 2 years | |
| Jason Davis | M | 52 | 2 years | |
| Graham Morrell | M | - | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Cameron Shaw | M | 37 | 10 years | |
| James Bradley Lorens | M | - | 14 years | |
| Richard Stuart Godfrey | M | 58 | 13 years | |
| Stener Kvinnsland | M | 76 | 7 years | |
| Hani Gabra | M | - | 3 years | |
| E. Gwyn Thomas | M | - | 1 years | |
| Andres McAllister | M | 68 |
Debiopharm International SA
Debiopharm International SA Pharmaceuticals: MajorHealth Technology Debiopharm International SA operates as a biopharmaceutical development company with focus on biologics and drug evaluation, licensing and development. It formulates and develops products for the treatment of cancer, endometriosis, uterine fibroids and hepatitis. The company was founded in 1979 and is headquartered in Lausanne, Switzerland. | 11 years |
| Alison Messom | M | 52 | 2 years | |
| Christine Deuschel Cornioley | M | - |
Debiopharm International SA
Debiopharm International SA Pharmaceuticals: MajorHealth Technology Debiopharm International SA operates as a biopharmaceutical development company with focus on biologics and drug evaluation, licensing and development. It formulates and develops products for the treatment of cancer, endometriosis, uterine fibroids and hepatitis. The company was founded in 1979 and is headquartered in Lausanne, Switzerland. | 23 years |
| Gro Gausdal | M | - | 8 years | |
| Chris Freitag | M | 58 |
Debiopharm International SA
Debiopharm International SA Pharmaceuticals: MajorHealth Technology Debiopharm International SA operates as a biopharmaceutical development company with focus on biologics and drug evaluation, licensing and development. It formulates and develops products for the treatment of cancer, endometriosis, uterine fibroids and hepatitis. The company was founded in 1979 and is headquartered in Lausanne, Switzerland. | 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Norway | 18 | 60.00% |
| United Kingdom | 8 | 26.67% |
| Switzerland | 4 | 13.33% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Nigel McCracken
- Personal Network
